Related Experiment Video
Updated: Aug 9, 2026

Use of a Percutaneous Ventricular Assist Device/Left Atrium to Femoral Artery Bypass System for Cardiogenic Shock
Published on: August 16, 2021
Levosimendan for post-partum cardiomyopathy
1Intensive Care Unit, St John of God Hospital, Subiaco, Western Australia. hdnguyen@graduate.uwa.edu.au
Objective:
To describe the use of levosimendan, a novel inotropic agent, for the treatment of post-partum cardiomyopathy (PPCMO).
Methods:
The authors present the second recorded use of levosimendan for a woman with PPCMO.
Results:
Levosimendan improved cardiac performance which was associated with symptomatic relief and echocardiographic improvement in ventricular function. The patient recovered from this episode of acute cardiac failure and continues to show steady improvement in cardiac function.
Conclusions:
Levosimendan proved a useful agent when used as initial therapy in this case of PPCMO.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy VII: Pre and Post Operative Nursing Management
Cardiomyopathy VI: Nursing Management
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy V: Interprofessional Care